Journal of Materials Chemistry B is a prestigious peer-reviewed journal published by the Royal Society of Chemistry, specializing in the latest advancements in the realm of materials chemistry. With a profound impact in the scientific community, this journal has achieved impressive Q1 quartile rankings in 2023 across several categories, including Biomedical Engineering, Miscellaneous Chemistry, Materials Science, and Medicine, illustrating its pivotal role in interdisciplinary research. Its impressive Scopus rankings further emphasize its widespread recognition, with notable placements in the top percentiles for various fields. Covering a broad scope of topics from novel materials for biomedical applications to innovative chemical synthesis techniques, the journal aims to promote knowledge exchange and foster collaborative research across disciplines. Although not an open-access journal, it offers a platform for researchers to share their findings and contribute to the evolving discourse within materials science. With a publication record spanning from 2013 to 2024, the Journal of Materials Chemistry B remains an essential resource for researchers, professionals, and students dedicated to exploring the frontiers of materials chemistry.

CELLS TISSUES ORGANS is a renowned academic journal published by KARGER, focusing on pivotal research within the fields of Anatomy and Histology. Based in Switzerland, this journal has been disseminating influential scientific findings since 1889, contributing to our understanding of cellular structures and tissue functionality. With a current impact factor that places it in the Q2 quartile for both disciplines, it serves as a vital resource for researchers, professionals, and students seeking to stay abreast of significant advancements and discussions in these areas. The journal embraces an Open Access model, ensuring that high-quality, peer-reviewed articles are freely available, thus enhancing visibility and accessibility of critical research. As it continues to foster scholarly communication and innovation up to 2024, CELLS TISSUES ORGANS plays a crucial role in shaping the future of biological sciences and medical research.

Bio-Design and Manufacturing, published by SPRINGER HEIDELBERG, is a pioneering journal that stands at the forefront of innovation in the fields of Biomedical Engineering, Biotechnology, Industrial and Manufacturing Engineering, and Materials Science. With its ISSN 2096-5524 and E-ISSN 2522-8552, this journal has established itself as a leading platform for disseminating cutting-edge research and advancements that merge biological principles with manufacturing processes, emphasizing sustainable and efficient practices. It has garnered recognition in the 2023 category quartiles, boasting a Q1 rank in all its relevant fields, which underscores its significance and impact—evident from its prime Scopus rankings that place it within the top percentiles of numerous engineering and materials science disciplines. Researchers, professionals, and students alike benefit from the wealth of knowledge presented in this journal, making it an essential resource for those seeking to enhance their understanding of bio-design applications and innovation in manufacturing processes.

The International Journal of Biomaterials, published by HINDAWI LTD, is a premier platform for disseminating groundbreaking research in the fields of biomaterials and biomedical engineering. With an Open Access approach since 2009, this journal provides unhindered access to innovative studies and applications aimed at advancing medical technologies and improving patient outcomes. Notably ranked in the Q3 category for both Biomaterials and Biomedical Engineering in 2023, it serves as an essential resource for researchers, practitioners, and students alike. The journal's Scopus rankings, including a 49th percentile in Biomedical Engineering and a 40th percentile in Biomaterials, further underscore its growing prominence in the academic community. With contributions spanning from 2011 to 2024, the journal seeks to foster collaborative research and promote developments that enhance the understanding and application of biomaterials in healthcare.

Biofabrication, published by IOP Publishing Ltd, stands at the forefront of the interdisciplinary fields of biochemistry, bioengineering, biomaterials, biomedical engineering, biotechnology, and miscellaneous medicine. Since its inception in 2009, this prestigious journal has secured its position within the Q1 category across multiple disciplines as of 2023, reflecting its high impact and significant contribution to advancing research in these domains. With ranks such as #19 in biochemistry and #10 in biomaterials according to Scopus, it showcases groundbreaking studies and innovative methodologies that are crucial for the evolution of biofabrication technologies. Authored by leading researchers and professionals, the journal publishes articles that explore the synthesis, characterization, and application of biomaterials, providing valuable insights for both academic researchers and industry practitioners. The impact factor of the journal, combined with its rigorous peer-review process, guarantees high-quality content that pushes the boundaries of knowledge and technology. Researchers and students engaged in these dynamic fields will find Biofabrication an indispensable resource for staying abreast of critical developments and emerging trends.

Tissue Engineering Part B-Reviews is a premier academic journal published by MARY ANN LIEBERT, INC, focusing on the interdisciplinary field of tissue engineering and regenerative medicine. With an impressive impact factor that places it in the Q1 category across multiple relevant fields—including Biochemistry, Bioengineering, Biomaterials, and Biomedical Engineering—this journal provides a vital platform for researchers and professionals to disseminate cutting-edge findings and comprehensive reviews. Covering a vast scope from 2008 to 2024, the journal is committed to advancing knowledge in the application of engineering principles to biological tissues, making it an indispensable resource for those at the forefront of biomedical innovation. While the journal does not currently offer open access options, its rigorous peer review process ensures high-quality contributions that are essential for academic and practical advancements. The journal's rankings in Scopus reflect its significance, catering to a diverse audience of students, researchers, and practitioners seeking the latest insights in this dynamic field.

Biomaterials Research, published by the American Association for the Advancement of Science, is a prominent open access journal established in 2014, dedicated to advancing the field of biomaterials. Based in the United Kingdom, this journal has swiftly become an essential platform for researchers and practitioners, offering groundbreaking insights in biomaterials, biomedical engineering, ceramics and composites, and miscellaneous medical fields. With its impressive Q1 ranking across multiple relevant categories in 2023 and its strong Scopus rankings, including a remarkable 90th percentile in the medicine category, Biomaterials Research showcases high-quality, peer-reviewed research designed to address both practical and theoretical challenges in biomaterials science. As an open access journal, it promotes wider dissemination and accessibility of research findings, crucial for fostering innovation and collaboration within the scientific community. Researchers, professionals, and students alike are encouraged to contribute, read, and engage with the latest developments in this dynamic field.

Biomaterials Science is a premier journal published by the Royal Society of Chemistry that serves as a leading platform for researchers and professionals in the fields of Biomedical Engineering and Materials Science. With an impressive impact factor bolstered by its Q1 quartile ranking in both disciplines, this journal has positioned itself at the forefront of cutting-edge research, showcasing innovative materials and applications that drive advancements in healthcare and technology. Since its inception in 2013, Biomaterials Science has been committed to disseminating high-quality, peer-reviewed articles that promote scientific knowledge and collaboration among academia and industry. With a global readership and a focus on open access, researchers are encouraged to share their findings to facilitate the development of transformative biomaterials and their applications. Join a vibrant community of scholars as we explore the future of biomaterials through this esteemed publication, enhancing both scientific inquiry and practical application.

Advanced Therapeutics, published by WILEY in the United Kingdom, stands at the forefront of medical and pharmaceutical research, offering invaluable insights from 2018 to 2024. This distinguished journal, with an E-ISSN of 2366-3987, is recognized for its exceptional academic rigor, boasting an impressive array of Q1 categorizations in essential fields such as Biochemistry (medical), Pharmaceutical Science, and Pharmacology. With its strategic focus on interdisciplinary studies and cutting-edge therapeutic developments, Advanced Therapeutics serves as a vital resource for researchers, professionals, and students keen on advancing their knowledge and contributing to the evolving landscape of medicine and genetics. The journal's high Scopus rankings further affirm its impact, with significant placements in multiple categories underscoring the quality of published research. Although the journal operates under a subscription model, its accessibility to high-impact findings ensures that it remains a pivotal platform for innovative discourse in therapeutics.

Acta Biomaterialia, published by Elsevier Science Ltd, is a leading journal in the fields of biochemistry, biomaterials, biomedical engineering, biotechnology, and molecular biology. With an ISSN of 1742-7061 and an E-ISSN of 1878-7568, this prestigious journal has secured a remarkable position in the academic community, evidenced by its inclusion in the Q1 category across multiple disciplines for 2023. It ranks impressively at #21 in biochemistry, #16 in biomedical engineering, #18 in biotechnology, and #11 in biomaterials, reflecting its high impact and relevance to ongoing research and development. The journal provides a platform for disseminating innovative research and advancements in the design and application of biomaterials, contributing to scientific discussions that propel the field forward. Although it does not currently offer open access options, Acta Biomaterialia continues to attract contributions that advance our understanding of biomaterials and their interactions with biological systems, ensuring that researchers, professionals, and students remain informed about the latest trends and breakthroughs in this rapidly evolving area of study.